Podcast appearances and mentions of boris jordan

This fireside discussion offers a deep dive into the expansion plans and business objectives for Curaleaf International; their strategies for entering new global markets, potential regulatory challenges, and how they plan to leverage their position as a leading cannabis company. Join us at Cannabis Europa 2025 www.cannabis-europa.com Keep up to date with the company's vision for global growth, potential partnerships, and innovations in product offerings. Join us for a fireside chat with Curaleaf Executive Chairman, Boris Jordan and Omar Sacirbey, Editor at MJBiz Magazine.

Our prayers do make a difference! And even more so when we pray in unity for something or someone. This is a heartwarming story of a church who prayed in unity for a dying baby girl. 

The lack of guidance from the US Federal Government on the cannabinoid industry poses significant challenges for those involved in the sector. The absence of clear regulations and leadership complicates business operations.In contrast, European countries are both legalizing cannabis and planning further legalization. They are keen to avoid the mistakes made by many US states and are learning from past failures.This week, we sit down with Boris Jordan to discussHow the NGC acquisition will drive Curaleaf's growth in Europe &Why Curaleafs in the Hemp MarketFruitStiq, Hemp Beverages, and so much moreAbout Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, and Grassroots provide industry-leading service, product selection and accessibility across the medical and adult use markets. In the United States, our brands are sold in 17 states with operations encompassing 147 dispensaries and employing more than 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF.#CURA #BorisJordan #CuraleafFollow us: Our Links.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain The Dime is a top 5% most shared  global podcast The Dime is a top 50 Cannabis Podcast Sign up for our playbook here:

The lack of guidance from the US Federal Government on the cannabinoid industry poses significant challenges for those involved in the sector. The absence of clear regulations and leadership complicates business operations.In contrast, European countries are both legalizing cannabis and planning further legalization. They are keen to avoid the mistakes made by many US states and are learning from past failures.This week, we sit down with Boris Jordan to discussHow the NGC acquisition will drive Curaleaf's growth in Europe &Why Curaleafs in the Hemp MarketFruitStiq, Hemp Beverages, and so much moreAbout Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, and Grassroots provide industry-leading service, product selection and accessibility across the medical and adult use markets. In the United States, our brands are sold in 17 states with operations encompassing 147 dispensaries and employing more than 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF.#CURA #BorisJordan #CuraleafFollow us: Our Links.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain The Dime is a top 5% most shared  global podcast The Dime is a top 50 Cannabis Podcast Sign up for our playbook here:

The lack of guidance from the US Federal Government on the cannabinoid industry poses significant challenges for those involved in the sector. The absence of clear regulations and leadership complicates business operations.In contrast, European countries are both legalizing cannabis and planning further legalization. They are keen to avoid the mistakes made by many US states and are learning from past failures.This week, we sit down with Boris Jordan to discussHow the NGC acquisition will drive Curaleaf's growth in Europe &Why Curaleafs in the Hemp MarketFruitStiq, Hemp Beverages, and so much moreAbout Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, and Grassroots provide industry-leading service, product selection and accessibility across the medical and adult use markets. In the United States, our brands are sold in 17 states with operations encompassing 147 dispensaries and employing more than 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF.#CURA #BorisJordan #CuraleafFollow us: Our Links.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain The Dime is a top 5% most shared  global podcast The Dime is a top 50 Cannabis Podcast Sign up for our playbook here:

„Wie Demokratien sterben“, so hat ein aufsehenerregendes Buch geheißen vom amerikanischen Politikwissenschaftler Daniel Ziblatt. Das Buch sollte eine Warnung sein. Daniel Ziblatt hat sich lange damit beschäftigt, wie Demokratien in Europa und Lateinamerika in den letzten 100 Jahren gestorben sind und dann faschistische Regime die Macht übernommen haben. Und dann ist er draufgekommen, dass die Demokratien in Europa und USA genauso Anzeichen zeigen, die er bei sterbenden Demokratien festgestellt hat. Daniel Ziblatts neues Buch heißt „Die Tyrannei der Minderheiten“, und damit wirft er noch einmal einen tieferen Blick auf die amerikanische Demokratie. Boris Jordan hat sich gestern mit Daniel Ziblatt getroffen und ihn nach dem Zustand der Demokratie gefragt… Sendungshinweis: FM4, OKFM4, 24.05.2024, 17:00 Uhr

Today, we heard the welcome news that the DEA is agreeing with the HHS recommendation to move cannabis from Schedule I to Schedule III.  Boris Jordan, Executive Chairman of Curaleaf, joins at the top of the show to share his thoughts on the next steps in the process, the timing of a final ruling, potential risks along the way,  implications for institutional interest, and the specific impact of 280E on Curaleaf's business. Hirsh Jain, founder of Ananda Strategy, joins for the second half and helps us better understand the similarities between cannabis's path to legalization and what happened with gay marriage. He also gives his perspective on the time frame for the DEA final ruling, advances in medical research, and how Schedule III may impact state election outcomes. We close by asking Hirsh his biggest concerns about this process and potential stumbling blocks.  This was an exciting day. Thank you to our regular listeners, and welcome to the new ears learning about this space. 

Er habe noch nie einen Menschen getroffen, der Bäume nicht mag, sagt Pierre Ibisch. Und auch er gehört nicht zu denen: Professor Pierre Ibisch ist einer der gefragtesten Wald- und Naturschutzexperten Deutschlands. Gemeinsam mit Peter Wohlleben hat er den Bestseller „Waldwissen“ veröffentlicht. Pierre Ibisch ist studierter Biologe und Professor für „Nature Conservation“ an der Hochschule für nachhaltige Entwicklung Eberswalde. Im Gespräch mit Boris Jordan zeichnet Professor Ibisch ein recht düsteres Bild vom Wald als Ökosystem, das unter Klimawandel, Extremwetterlagen und dem „Holzhunger“ der Gesellschaft leidet – dabei sollten wir uns gerade im Hinblick auf den Klimawandel verstärkt und vernünftig darum kümmern, ihn zu retten. Sendungshinweis: OKFM4, 26.4.2024, 17 Uhr

"Great companies were never built by conservative leaders.Great companies were built by risk-takers."Deeply ingrained in Curaleaf's DNA is the ability to navigate the unknown ahead of opportunities.Timing these events is nearly impossible, but having the foresight and strategic resources in place when the opportunity strikes can change the game.For visionaries like Boris Jordan, being early in markets like Germany can be challenging for everyone to see until recent developments materialize.The US and European cannabis markets operate very differently, and Curaleaf is in a prime position to secure an untapped market share twice the size of the US.This week, we sit down with Boris Jordan to discuss the following:Unique Market Differences: Europe vs USEducating Institutional Investors: What does that conversation look like inside the room?Breakdown of the German Market, Hint toward AsiaAnd so much more About Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, and Grassroots provide industry-leading service, product selection and accessibility across the medical and adult use markets. In the United States, our brands are sold in 17 states with operations encompassing 147 dispensaries and employing more than 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. Follow us: Our Links.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain The Dime is a top 5% most shared  global podcast The Dime is a top 50 Cannabis Podcast Sign up for our playbook here:

"Great companies were never built by conservative leaders.Great companies were built by risk-takers."Deeply ingrained in Curaleaf's DNA is the ability to navigate the unknown ahead of opportunities.Timing these events is nearly impossible, but having the foresight and strategic resources in place when the opportunity strikes can change the game.For visionaries like Boris Jordan, being early in markets like Germany can be challenging for everyone to see until recent developments materialize.The US and European cannabis markets operate very differently, and Curaleaf is in a prime position to secure an untapped market share twice the size of the US.This week, we sit down with Boris Jordan to discuss the following:Unique Market Differences: Europe vs USEducating Institutional Investors: What does that conversation look like inside the room?Breakdown of the German Market, Hint toward AsiaAnd so much more About Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, and Grassroots provide industry-leading service, product selection and accessibility across the medical and adult use markets. In the United States, our brands are sold in 17 states with operations encompassing 147 dispensaries and employing more than 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. Follow us: Our Links.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain The Dime is a top 5% most shared  global podcast The Dime is a top 50 Cannabis Podcast Sign up for our playbook here:

"Great companies were never built by conservative leaders.Great companies were built by risk-takers."Deeply ingrained in Curaleaf's DNA is the ability to navigate the unknown ahead of opportunities.Timing these events is nearly impossible, but having the foresight and strategic resources in place when the opportunity strikes can change the game.For visionaries like Boris Jordan, being early in markets like Germany can be challenging for everyone to see until recent developments materialize.The US and European cannabis markets operate very differently, and Curaleaf is in a prime position to secure an untapped market share twice the size of the US.This week, we sit down with Boris Jordan to discuss the following:Unique Market Differences: Europe vs USEducating Institutional Investors: What does that conversation look like inside the room?Breakdown of the German Market, Hint toward AsiaAnd so much more About Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, and Grassroots provide industry-leading service, product selection and accessibility across the medical and adult use markets. In the United States, our brands are sold in 17 states with operations encompassing 147 dispensaries and employing more than 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. Follow us: Our Links.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain The Dime is a top 5% most shared  global podcast The Dime is a top 50 Cannabis Podcast Sign up for our playbook here:

This week's show had an all-star cast to review recent earnings. CannaVestments shared his thoughts on the federal and state-level catalysts in 2024 and contrasted this against eroding investor sentiment. He also gave his perspective on the recent results from GTI, Verano, and Trulieve. Boris Jordan, Executive Chairman of Curaleaf, joined the show to review the company's Q4 2023 earnings.  He also covered how 280E removal would benefit the business, the results of their recent institutional road show, and thoughts on the rapidly evolving hemp-derived cannabinoids business. If you enjoyed this episode, please leave a five-star review on your favorite podcast platform. It helps new investors find the show and grows the cannabis-investing universe!

This week's show begins by discussing the Benzinga cannabis conference in Los Angeles. Morgan and Jesse left inspired by the strength of brands, the quality of products, and the lack of focus on politics. Boris Jordan, Executive Chairman of Curaleaf, joined to discuss the recent events in Germany. He shares how he sees the program evolving and the economic opportunity for Curaleaf. Earnings season starts next week and the group weighs in on what they are looking for in the quarterly reports and calls. Price compression, revenue growth, cost controls, and how operators are handling 280E are all top of mind. The episode concludes with a new segment called Ask Grok (X's new AI tool) and this week we ask when cannabis will be rescheduled.

Bloomberg Intelligence Senior Retail Analyst Mary Ross Gilbert discusses Macy's saying that it isn't interested in a bid from Arkhouse Management Co. and Brigade Capital Management to take over the retailer. Bloomberg Opinion Columnist Bill Dudley, former President Federal Reserve Bank of New York, shares his thoughts on monetary policy ahead of the upcoming FOMC meeting and Bloomberg News International Economics & Policy Correspondent Michael McKee breaks news on the results of the Federal Reserve's inspector general's investigation into trading by former Fed officials at the height of the pandemic. Boris Jordan, Executive Chairman at Curaleaf, talks about looking for a rebound year for the cannabis industry in 2024. And we Drive to the Close with Nancy Tengler, Chief Investment Officer at Laffer Tengler Investments. Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan. See omnystudio.com/listener for privacy information.

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.     Bloomberg Intelligence Senior Retail Analyst Mary Ross Gilbert discusses Macy's saying that it isn't interested in a bid from Arkhouse Management Co. and Brigade Capital Management to take over the retailer. Bloomberg Opinion Columnist Bill Dudley, former President Federal Reserve Bank of New York, shares his thoughts on monetary policy ahead of the upcoming FOMC meeting and Bloomberg News International Economics & Policy Correspondent Michael McKee breaks news on the results of the Federal Reserve's inspector general's investigation into trading by former Fed officials at the height of the pandemic. Boris Jordan, Executive Chairman at Curaleaf, talks about looking for a rebound year for the cannabis industry in 2024. And we Drive to the Close with Nancy Tengler, Chief Investment Officer at Laffer Tengler Investments. Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan. See omnystudio.com/listener for privacy information.

This week Jesse, Morgan, and Toby discussed the release of the HHS rescheduling recommendation. For the first half hour, Brady Cobb, Founder and CEO of Sunburn Cannabis, shares his perspective on the contents and timing of the release.  He also adds his thoughts on the implications of 280E removal and how he thinks about it from an operator's perspective. Higher Exchanges is recorded live on X and Boris Jordan, Executive Chairman of Curaleaf, was listening and joined for the latter half of the episode. Boris shares his thoughts after reading the full 252-page document, updates us on Curaleaf's roadshow, and how and when institutions may participate in the sector. 

Toby is on vacation, so Jesse and Morgan kick off the show discussing recent performance and the latest Schedule III speculation. Jesse shares data on different portfolios he's tracking that may indicate what types of stocks will perform best in the event we get positive news from the DEA.Curaleaf Executive Chairman Boris Jordan joins halfway through to discuss the company's uplisting from the CSE to the TSX. Boris shares Curaleaf's roadshow plans, and benefits of the uplisting, and gives his latest perspective on the probabilities and impact of federal reform. The show concludes with Morgan explaining the widespread impact of the hemp-derived cannabinoids. This market is beginning to rival the legacy market in scale and impact, especially in states without legal cannabis programs. 

MarketWatch's Steve Gelsi sits down with Boris Jordan, chairman of the U.S.'s largest legal cannabis company, Curaleaf, about the rise of legalization, the potential federal re-scheduling of cannabis, and what that means for the industry.

Boris Jordan, Executive Chairman of Curaleaf, joins the show to discuss the latest updates on their Toronto Stock Exchange (TSX) application, SAFER Banking, and rescheduling. He shares an approximate date for uplisting to the higher exchange and explains how the increased liquidity and access may benefit Curaleaf shareholders. Boris also covers the potential impacts of a new Speaker of the House on SAFER Banking and theorizes on when we may hear back from the DEA on Schedule III. In addition, Jesse, Morgan, and Toby discuss the radical recent shift in sentiment and whether the more dour perspective is warranted. Plus, the group debates the relative importance of Florida moving to adult-use sales versus SAFER Banking. 

#85 | Interview of Boris Jordan | Curaleaf | Founder | Cannabis Stocks | Boris Jordan Joins us for Exclusive Interview w/ Hosts @AviNMash | @StockSavvyShay | and a SPECIAL GUEST Alexander "Zander" Abrams  Want to Contact Us?  Email us at Hosts@PoundingTheTablePodcast.comLegal Disclaimer:The thoughts and opinions expressed on this podcast, are solely for entertainment purposes and should not be construed as investment advice. The content provided is based on personal experiences, analysis, and general knowledge about stocks and the financial market.The information shared on this podcast is not intended to be a substitute for professional financial advice. Listeners should always consult with a qualified financial advisor or professional before making any investment decisions. Investing in stocks and other financial instruments carries inherent risks, and individuals should carefully consider their own financial situation, risk tolerance, and investment goals before engaging in any investment activities.The hosts and guests on this podcast are not licensed financial advisors or professionals. They are sharing their personal opinions and experiences, which may not be suitable for everyone. The accuracy, completeness, and timeliness of the information presented cannot be guaranteed, as the stock market and investment landscape are subject to constant changes.Any actions taken based on the content of this podcast are done at the listener's own risk. The podcast hosts, guests, and producers assume no responsibility or liability for any investment decisions, losses, or damages incurred as a result of the information provided on the podcast.

The slow rolling legalization of cannabis in the United States is providing an interesting investment opportunity. Since Covid, cannabis sales are up tremendously. The legal industry is growing as more states legalize medicinal and/or recreational use. As large, licensed multiple state cannabis operations grow, they are increasingly cashflow positive. All of this despite having no access to the US banking system and paying a particularly high effective tax rate – frequently north of 70%.  In the beginning of 2021, banks, wary of unclear Federal law, began to prevent their brokerage clients from investment in public cannabis companies. Since that time, we've seen these stocks fall over 80% in valuation. At the same time, fundamentally, the businesses continue to grow and thrive.  As we speak, the lame duck Congress is considering legislation that would open up the banking system to state-licensed cannabis companies. My guest today addressing the state of the industry is Boris Jordan. Boris is the Founding Partner of cannabis-dedicated asset manager Measure 8 Venture Partners, as well as Chairman of Curaleaf, which he founded and built into the world's largest cannabis company. Prior to his current focus in cannabis, Boris had a legendary career as a banker and private equity manager in emerging markets starting in the 1990's.. This podcast was recorded on December 6,  2022.  The respective opinions expressed are those of Mr. Jordan and the Biltmore Family Office, LLC investment team.  The opinions referenced are as of the date of this podcast and are subject to change without notice.  This material is for informational use only and should not be considered investment advice. The information discussed herein is not a recommendation to buy or sell a particular security or to invest in any particular sector.  Forward-looking statements are not guaranteed.  BFO reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs and there is no guarantee that their assessment of investments will be accurate.  The discussions, outlook and viewpoints featured are not intended to be investment advice and do not take into account specific client investment objectives.  Before investing, an investor should consider his or her investment goals and risk comfort levels and consult with his or her investment adviser and tax professional.   Biltmore Family Office, LLC is an investment adviser registered with the U.S. Securities and Exchange Commission. Registration does not imply a certain level of skill or training. More information about BFO's investment advisory services can be found in its Form ADV Part 2, which is available upon request.

Boris Jordan is a fascinating figure. An American of White Russian ancestry, he played a pivotal role in Russia's roller coaster economic transformation during the 1990s. Today he is best known as the founder, executive chairman and principal shareholder of Curaleaf, which is in many respects the world's largest cannabis company. We started off by talking about the politics of marijuana reform in Congress but then focused on the future of the cannabis industry. What role will Big Tobacco, Big Pharma, Big Alcohol and the other big consumer good companies eventually play? Which countries, not just in Europe but also in Asia, Africa and the Middle East, are most likely to legalize cannabis in coming years? Why does he think cannabis beverages will account for half of the cannabis market within ten years? What does he think about the future of legal psychedelics? And how and why did he get involved in this industry in the first place?See omnystudio.com/listener for privacy information.

Live from Chicago's Benzinga Cannabis Capital Conference with Fast Money's Tim Seymour! Why MSOs are still the most interesting investments but some are separating from others. Tim's conversation with Boris Jordan. Oversupply in the market. People aren't as optimistic and why that's a good thing.

Welcome to another episode of "Cannabis Daily"!  This is our 500th episode.  Please check our socials (below) as we'll be counting down our Top 10 favourites from the archive.Here are today's stories:Curaleaf's relationship to Russia under scrutinySaskatchewan's Mother Labs received $1.8 million in federal fundingMEPs create working group focused on cannabis for personal useCeladon posts its first update since going publicTweet us and let us know your thoughts, here.Email us about our stories, here.Missed the previous episode? You can catch up with it here.  About Cannabis Daily.Cannabis Daily is a cannabis news and interview program from Business of Cannabis. We highlight the companies, brands, people and trends driving the cannabis industry.Business of Cannabis is a cannabis industry platform marrying cannabis news, video and podcast content, newsletters and online and real-world cannabis events.Visit Business of Cannabis online:http://businessofcannabis.comTwitter: https://twitter.com/bofc_mediaLinkedIn: https://www.linkedin.com/company/businessofcannabisInstagram: https://instagram.com/businessofcannabisFacebook: https://www.facebook.com/bofcmediaSpotify: http://bofc.me/spotifyApple: http://bofc.me/applepodPodcasts Online: https://bofc.me/bofclive

Katja Lewina, geboren in Moskau und als Kind nach Deutschland übersiedelt, hat mit ihrem Buch "Sie hat Bock" eines der meistbeachteten Bücher über weibliche Sexualität der letzten Jahre verfasst. In "Sie hat Bock" beschreibt Lewina ihre eigenen Erfahrungen als hetereosexuelle, promiskuitive, sexuell aktive und selbstbewusste Frau und setzt sich und ihre Geschlechtsgenossinnen darin in eine Beziehung zu Gesellschaft, Partiarchat und Feminismus. Im Nachfolgeband "Bock" beleuchtet Lewina die männliche Sexualität, mit Hilfe von Interviews, die sie mit Männern aller Altersklassen und Lebensphasen geführt hat. Lewina plädiert für eine aktive und erfüllende Sexualität mit Hilfe von Konsens, Varietät , Ehrlichkeit und , vor allem, Kommunikation. Boris Jordan hat mit Katja Lewina en ausführliches Gespräch geführt, über Beziehung, Ehe, Oralsex, Masturbation, Pornografie und viel mehr.

Welcome to Cannabis Daily - Your daily guide to cannabis news, industry trends, and trade ideas in under 5 mins.Episode Summary:Sundial Growers (NASDAQ: SNDL) will be acquiring Alcanna announced an extension of the agreement outside date to March 30th, 2022.Flora Growth(NASDAQ: FLGC) completed an acquisition of JustCBD. This will massively enhance the company's us infrastructure. TILT Holdings (OTCQX:TLLTF) to launch a cannabis delivery service in Massachusetts. Curaleaf Holdings(OTCQX: CURLF) : EXCLUSIVE: Curaleaf's Boris Jordan Responds To Russia-Related Allegations: 'Rumors & Misinformation Spread During Turbulent Times'Elliot's Watchlist for today:Sundial Growers (NASDAQ: SNDL) Verano Holdings(OTCQX:VRNOF)TILT Holdings (OTCQX:TLLTF) Goodness Growth Holdings(OTCQX: GDNSF)SugarBud Craft Growers(OTCQB: SBUDD)Hosted & Produced By:Elliot LaneAaron ThomasContact us at: cannabishour@benzinga.comFollow Benzinga Cannabis On Social MediaInstagramTwitterYouTubeLinkedInSubscribe to all Benzinga Podcasts at https://www.benzinga.com/podcastsSubscribe to the Cannabis Insider Newsletter to get more cannabis news and trending links delivered to your inbox.Tune in weekly to Cannabis Hour at 4 pm ET every Thursday for Cannabis News & Executive Interviews at bzcannabishour.comHit us up at https://www.benzinga.com/cannabis/ for more news today, tomorrow, and everyday.Access All The Cannabis Daily Episodes HereFor Top Gainers & Losers Cannabis stocks of the day check out https://www.benzinga.com/cannabis/stocksNOT FINANCIAL ADVICEThe Information Contained on this Podcast is not intended as, and shall not be understood or construed as, financial adviceUnedited Transcript:Good morning investors, happy Monday. Hope you all had a lively, fun and or relaxing weekend, whatever you want to do. I hope you did it now. If you're ready to dive into another exciting week of cannabis industry news and stocks.Get right to it as always. Thanks to Aaron Thomas. Thanks to Asli Thanks to Benzinga for everything you do to make this happen rate and review us, let us know what you think and come meet me. April 20th through 21st on Miami beach for our first 2022 canvas capital conference. However, we got some news to cover.European commission makes to welcome updates for the CBD and. At least five companies in the EU have received news that their novel food CBD cases have reached the final stages. This will impact hemp production very positively for Europe. The second update is the European commission panel is to vote on THC levels in food. Obviously food with cannabidiol. In it, which will help set standards in cultivation that are long overdue. So it's nice to see these developments happen. It's been several years that some of these have been put on delay and ideally we will see this move a little bit. I, it is interesting to see this happen now of all times in Europe, but it is a positive development for sure.Sugar, bud S B U D on the OTC markets, a craft cannabis grower in Canada launches a new GMO, highly. Dry flower cookie product in Ontario, specifically that move it's 30% dry flower. So that is a nice update to their product portfolio. Keep them on your watch list. Craft grows will become an interesting part of the Canadian space.There are hundreds of licensed producers in that market, so they will have to stick out. And I think sugar bud has an interesting model to do so zine Nerva. Yeah. Zaner about Z Y. He announces completion of enrollment in a 14 week phase two trial for XY gel. Is a leading cannabidiol biotech in the space.XY gel is being developed to assist with behavioral symptoms of deletion syndrome in children and adolescent. Last week, you may have noticed curely take a little bit of a hit that is due apparently to Boris Jordan, their chairman his ties to his ancestry will say in both, I believe Russia and Ukraine. But he did release a letter through Benzinga channels on Friday. He denounced any active sympathetic ties to Russia outside of the hope for peace between the two nations sundial and Al Canada announced an extension of agreement outside date to March 30th, 2022 sundial will be acquiring Al Canada.Ideally, we all want this to go through Al Kana adds an extensive distribution network to sundial, as well as introducing the company to the alcohol sales. West Virginia House approved a bill to limit medical marijuana testing licenses. The, this will be a limit for two companies statewide to test the measure will go to the Senate.Mad men, M N F on the OTC announces the sale of their Florida assets, four $83 million in cash. This includes medical cannabis, license, inventory, and operations. Big news again, out of four growth Corp that's FLDC on the NASDAQ. They complete an acquisition of just CBD. This will massively enhance the company's us infrastructure and CBG portfolio over 300 portfolio brand products for just CBD.They have a direct to consumer business with over 300,000 customers and a network of 14,000 stores across the us and internationally just CBD generated around $28 million in revenue in 2020 goodness growth launches, a full line of cannabis flower in Minnesota. Obviously this is a huge boon for both goodness growth and Verano who announced their intent to acquire goodness growth and last but not least for the day.Tilt holdings T L T F. Whenever they come out with news, they mean it. They are going to launch a cannabis delivery service from its Commonwealth alternative care Taunton dispensary in Massachusetts. If I'm looking at who to watch the. On a positive note, I'm looking at flora growth Corp, for sure.I'm looking at tilt holdings. I'm probably looking at Verano V R N O F on the OTC as well as goodness growth with that being said the major players are getting some pressure. Folks like Alan Braxton from new cannabis ventures expect more stock selling to come. Hopefully not diluting too much of these major industry players keep an eye on the markets this week.I know it's crazy out there. Y'all but cannabis is still a roaring industry. Great fundamentals looking forward to getting more investors on board in this space. This is Elliot lane looking forward to seeing you. Support this podcast at — https://redcircle.com/cannabis-daily/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Welcome to Cannabis Daily - Your daily guide to cannabis news, industry trends and trade ideas in under 5 mins.Episode Summary:Oregon State research shows hemp compounds prevent coronavirus from entering human cellsAyr Wellness(OTCQX: AYRWF) opens 44th dispensary in Florida.Another stock to keep an eye on is Auxly Cannabis Group(OTCQX: CBWTF) It holds 23% market share in the vapor segment, in Canada, three vape products for Oxley placed in the top five across the country.Delta 9 Cannabis(OTCQX: DLTNF) making improvements year over yearDon't forget to tune in tomorrow for our special episode of cannabis stocks to watch in 2022.Hosted & Produced By:Elliot LaneAaron Thomas Contact us at: cannabishour@benzinga.comFollow Benzinga Cannabis On Social MediaInstagramTwitterYouTubeLinkedInSubscribe to all Benzinga Podcasts at https://www.benzinga.com/podcastsSubscribe to the Cannabis Insider Newsletter to get more cannabis news and trending links delivered to your inbox.Tune in weekly to Cannabis Hour at 4 pm ET every Thursday for Cannabis News & Executive Interviews at bzcannabishour.comHit us up at https://www.benzinga.com/cannabis/ for more news today, tomorrow, and everyday.Access All The Cannabis Daily Episodes HereFor Top Gainers & Losers Cannabis stocks of the day check out https://www.benzinga.com/cannabis/stocksNOT FINANCIAL ADVICEThe Information Contained on this Podcast is not intended as, and shall not be understood or construed as, financial adviceUnedited Transcript:Good morning investors. Happy Thursday. This is Elliot lane, host of cannabis daily. Thrilled to be back with you for fourth time this week on your second week of 2022.Thanks as always to Aaron Thomas, our fearless producer, as well as Benzinga for the platform. This show is designed. To bring you cannabis news and insights for investible information for the day. So let's dive right in tons to chat about today on multiple levels. And some things I can't leave off, but aren't necessarily focused on the public markets.Let's dive in Delta. DLT an F on the OTC provides guidance and timing for their financial year, 20, 21 year in results. They anticipate the quarter ending December 31st to bring in between 16.6 and 17.4 million. That is between a 17 and 23% increase year over year and nine and 14% quarter over quarter.That is in Canadian dollars fiscal year, 2021 results to be between. To be somewhere around 61.8 and 62.6 million compared to 52.1 million for fiscal year 2020. So Delta nine, definitely making improvements year over year and believe me y'all there are some good businesses in this industry in Canada.Let's not forget about them. Delta nine is one of them, one of the OGs in the Canadian. Next up the talk of the town, I would say for the last 24 or so hours a study out of, I believe it's Oregon state university says cannabis may block and or help people to not get COVID or SARS COVID 19. This is a huge, funny and people such as Jimmy Kimmel are saying, why are we listening to the CDC when we could just take CBD?So with that being said I may look at my daily routine and add in some more cannabis. We'll see Huxton cannabis announces plans to bring weed to metaphor. People like relating to objects they know, and this could give them the option to get digitally stoned. I will let you all create your own opinions about this.I just ask why pure extracts, P R X T F on the OTC signs, a white. Custom manufacturing license agreement with a west coast licensed producer to be named, to launch a line of vape products, not a stock. We talk about a lot, but one that's been around and active for several years now, Austin, Texas will have a decriminalization initiative on the ballot.Other Texas cities will soon to follow activists for cannabis in the state have had little success on that level statewide in cannabis reforms. They're starting to turn their attention to the local level per normal in O R N O R M l.org. If you want to read more on that, this seems pretty big to me and slightly disappointing that we're still not in agreement over this, but Virginia law makers are divided on releasing marijuana prisoners following legalization.10 people whose most serious offense is marijuana. I believe we're all set to be released in the next few years. So that may be part of the reason, but there's another 560 people are serving partially related to marijuana, serving sentences, partially related to marijuana. So something to keep an eye on.I do hope at least those 10 people are able to get out of their sentence a little early. executive chair that see you RLF on the OTC, their executive chair, Boris Jordan, and six others. I believe file a $60 million lawsuit against an Oregon CBD startup saying they were induced into funding with false and misleading information.Seven investors in the lawsuit are against Nitten Cana and a few others. The company's name was sending. S E N T I a. It was a spinoff of Cura partners. Its social CBD brand was sold to a California company last year for an undisclosed price. Kaunas attorney saying the company failed due to regulatory changes and COVID impact on cannabis retail. Boris Jordan, I believe investing in this either on his own or through measure. Venture partners, but I do not believe this has much to do with curely from after reading this audacious brands, Aus a completes their acquisition of Luce, L O S which is just how you spell the company. That is not a ticker, but I can't a cannabinoid infused shot beverage company in Santa Cruz, California.So audacious looking to expand their brand portfolio in the largest cannabis economy in the world. So good for them. We'll see how it, it affects their bottom line as they continue to roll that. Oxley cannabis, in my opinion, the winner of the day CBW T F on the OTC, I believe XLY on the TSX secured 15% market share in cannabis.2.0 product sales in 2021. 14% in, I believe 2020 driven by the dominance in the vapor segment where it holds 23% market share 23% market share into the vapor segment in Canada, three vape products for Oxley securing top five spots across the country. So Oxley again, ticker CB WTF has been ripping and roaring. The past, I would say six to eight months or so they really have burst onto the scene and become a major player in the Canadian market. Some would argue a little bit longer than that, but I really think that's been the time to keep an eye on this stock air wellness Ayr WF opens 44th dispensary.Florida. Thank you all so much for tuning in tomorrow. We are going to bring you a special episode. I'm going to do cannabis stocks to watch for 2022. I will do my best for you. We won't forget about the news. Aaron Thomas May come on and give us a few tidbits about what's going on. Culturally in the industry, but we do look forward this, look forward to doing this one more time tomorrow.This is Elliot lane. We'll see you then.Support this podcast at — https://redcircle.com/cannabis-daily/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Chairman of Curaleaf (large cannabis dispensary chain, multi-state operator), Boris Jordan, on CNBC sounding like Big Daddy Cannabis:  "Our competition isn't the other cannabis companies... the competition for us is the DRUG DEALERS pedaling non-regulated product"  https://podcasts.apple.com/us/podcast/we-bought-haverhill-7-cop-cars-to-bust-the-black/id1086374373?i=1000547011398 Curaleaf CEO Joseph Lusardi speaks with Bloomberg on how illegal dealers want to only get people high and make money! Like he doesn't want to make money while on Bloomberg a business network. Tuesday night at 7pm, THE YOUNG JURKS will be live with guest panelists, Michael Picard, Zach Williams.and more TBA. Watch live on our youtube, facebook, twitter, or twitch!  Thank you to @EyesOnMJ for the Boris Jordan clip.  --- Support this podcast: https://anchor.fm/theyoungjurks/support

In der heutigen Mittagsfolge sprechen wir mit Anna-Sophia Kouparanis, Co-Founder von Bloomwell Group. Das Frankfurter Cannabis-Startup schließt seine Seed-Runde in Höhe von 10 Millionen US-Dollar ab. Die Holdinggesellschaft Bloomwell Group hat sich auf Unternehmen im Bereich medizinisches Cannabis spezialisiert. Das Ziel ist es hierbei, den Firmen entlang der gesamten Wertschöpfungskette – mit Ausnahme des Anbaus – aufzubauen, zu erwerben und in sie zu investieren. Das Führungsteam von Bloomwell besteht aus Samuel Menghistu, Niklas Kouparanis (ehemaliger Gründer und Geschäftsführer beim Cannabis-Unternehmen Farmako), Julian Wichmann und Anna-Sophia Kouparanis. Das Telemedizin-Startup Algea Care sowie der Cannabis-Händler Ilios Santé gehören bereits zur Bloomwell Group. Teile des neuen Kapitals will das Führungsteam zudem für weitere Akquisitionen nutzen. An der Seed-Runde hat sich u.a. der US-amerikanische Milliardär Boris Jordan mit seinem Fonds Measure 8 Venture Partners beteiligt. Der russischstämmige Geschäftsmann wird außerdem im Zuge des Investments Mitglied des Aufsichtsrats. Ebenfalls dabei ist der Münchner Digital Health Frühphasen-Investor M4Capital. Mit diesem Investmentvolumen von über 10 Millionen US-Dollar soll es sich um das bis bislang höchste öffentlich bekannte Seed-Investment für ein europäisches Cannabis-Unternehmen handeln. Wenn auch Du Dein Lieblingstool bewerten willst, schreibe eine Review auf OMR Reviews. Dafür erhältst du einen 20€ Amazon Gutschein. https://moin.omr.com/insider

Von der türkisen Verharmlosung im Sommer zum Teillockdown im Herbst. In diesem Podcast hören Sie wie Österreichs Regierung den Kampf gegen die Pandemie erschwert. Es diskutieren Politikwissenschaftlerin Natascha Strobl, Virologin Janine Kimpel, Medizinhistoriker Philipp Osten und Wiener Kulturstadträtin Veronica Kaup-Hasler im Wiener Volkstheater (Roter Salon). Moderiert wird das Gespräch von Boris Jordan. Außerdem zu hören: ORF-Journalistin Elke Ziegler bei der Verleihung des Robert Hochner-Preises.An- und Abmoderation spricht Raimund Löw.Lesen Sie den FALTER vier Wochen lang kostenlos: https://abo.falter.at/gratis See acast.com/privacy for privacy and opt-out information.

Natascha Strobl ist Politikwissenschaftlerin und Expertin für Rechtsextremismus. In ihrem neuen Buch betritt sie allerdings eine „höhere“ Ebene. In „Radikalisierter Konservatismus“ beleuchtet Strobl das Phänomen, dass in Umbruchszeiten wie der Unseren auch traditionell konservative, staatstragende Parteien aus der Mitte der Gesellschaft sich ihrer christlichen oder wertorientierten Positionen entledigen und weiter nach rechts rücken. Dies passiert mit Hilfe klassisch rechter Strategien wie Kulturkampf, Medienbeeinflussung, tabubrechender Rhetorik und Personenkult. In ihrem bei Suhrkamp erschienenen Buch erläutert Strobl diese neue Strategien anhand der Erfolge von Donald Trump, Boris Johnson und Sebastian Kurz. Boris Jordan hat sich alles erklären lassen.

On this episode of BofC Live, we connect with Emily Paxhia of Poseidon - a long time investor and leader in the cannabis sector in North America and around the world. We wanted to connect with Paxhia to talk about her background investing in the cannabis sector since 2014 as well as the panel she hopes to present on at this year's SXSW festival. The cannabis track is a core component of SXSW and her panel - which you can pick - revolves around the international cannabis market and would feature Boris Jordan of Curaleaf, Stephen Murphy of Prohibition Partners and Javier Hasse of Benzinga alongside Paxhia.Vote for Global View: Cannabis on the World Stage panel.

Das Meer ist in aller Munde, könnte man sagen, wenn das nicht so ein schiefes Bild wäre… Im Hinblick auf Klimawandel und Artensterben steht der größte Lebensraum der Welt immer mehr im Fokus - sei es von Umweltschützer*Innen, Klimaexpert*innen oder auch wissenschaftlichen Disziplinen wie Energietechnik, Humanmedizin oder Biochemie. Nun ist ein besonders faszinierendes Buch über Meereslebewesen erschienen. Die Meeresbiologin Dr. Julia Schnetzer beschreibt in ihrem Buch „Wenn Haie leuchten“ mit einer Mischung aus staunender, fast kindlicher Faszination und wissenschaftlicher Genauigkeit allerlei erstaunliche Dinge, die wir von diesem Geheimnisvollen Ökosystem noch nicht wussten - Boris Jordan teilt diese Faszination und hat Julia Schnetzer übers Meer befragt.

In this episode we unpack last week's interview with Boris Jordan and review in-depth some of the interesting points he raised. We also do a deeper dive into the Trulieve - Harvest merger and share our thoughts on why it's a true value play and what Kim may be hoping to achieve post-integration.

In this jam-packed episode Boris Jordan joins us in an extremely candid conversation about Curaleaf Holdings. Boris is founder and Executive Chairman of Curaleaf Holdings and is one of the industry's most recognized faces. He is also a prolific cannabis investor having invested over $400M of hard cash into Curaleaf and more into other private cannabis opportunities. In this wide ranging discussion Boris shares stories and discussions on many topics including: - The First Inning of Curaleaf: how it all started and where we are now - Compliance & Custodying: how the recent compliance forced institutional selling is a repeat of 2019 - Guidance: What is driving the massive Q2 growth Curaleaf is projecting? - Interstate Commerce: why Boris thinks it is inevitable and how they are planning for it - Driving Down Costs: Technology that could cut manufacturing cost by 90% - Being National: Why it's important to be in highly competitive markets like California and Oregon - Wide & Deep: How the recent Trulieve & Harvest merger validates Curaleaf's early thesis - Florida: what mistakes were made, how they were fixed and the future - Cost of Capital: refinancing Curaleaf debt in 2022 at 7-8% without warrants - Private Investing: How Boris fills the "venture investing" role for Curaleaf - Being the Biggest: Why it matters - Margins & Growth: How Curaleaf compares to its competition - M&A: The importance of Select & Grassroots - Mistakes: Learning from past issues Thank you to Boris Jordan for joining us for this episode!

Boris Jordan, Executive Chairman at Curaleaf, discusses acquisitions, earnings and accommodating increased demand. Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

We get the Businessweek Agenda with Bloomberg News International Economics & Policy Michael McKee and Bloomberg Stocks Editor Dave Wilson. Bloomberg News Congressional Tax Reporter Laura Davison discusses a record $2 trillion U.S. government stimulus package. Dr. Ian Lustbader, Clinical Professor of Medicine at NYU, provides an update on the coronavirus and telemedicine surging. Bloomberg Businessweek Editor Joel Weber and Bryan Gruley, P&I Reporter for Bloomberg News, share their insight on how 3M is working to double the production of N95 masks. Boris Jordan, Executive Chairman at Curaleaf, talks about how the medical cannabis company is dealing with the coronavirus. And we Drive to the Close with John Lovito, Co-CIO of Global Fixed Income. Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com